Edition:
United Kingdom

NewLink Genetics Corp (NLNK.OQ)

NLNK.OQ on NASDAQ Stock Exchange Global Market

1.88USD
16 Nov 2018
Change (% chg)

$-0.21 (-10.05%)
Prev Close
$2.09
Open
$2.05
Day's High
$2.10
Day's Low
$1.83
Volume
161,868
Avg. Vol
115,582
52-wk High
$10.40
52-wk Low
$1.83

Chart for

About

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $387.58
Shares Outstanding(Mil.): 36.22
Dividend: --
Yield (%): --

Financials

  NLNK.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -2.29 -- --
ROI: -50.00 -0.64 15.05
ROE: -52.94 0.08 16.62

Earnings vs. Estimates